- Home
- PLSE vs CIM Comparison
PLSE vs CIM Comparison
Compare PLSE & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSE | CIM |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2016 | 2007 |
Fundamental Metrics
Financial Performance| Metric | PLSE | CIM |
|---|---|---|
| Price | $14.81 | $12.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $22.00 | $15.25 |
| AVG Volume (30 Days) | 198.5K | ★ 847.5K |
| Earning Date | 11-05-2025 | 02-11-2026 |
| Dividend Yield | N/A | ★ 11.79% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $86,000.00 | ★ $191,573,000.00 |
| Revenue This Year | N/A | $11.44 |
| Revenue Next Year | $1,002.94 | $21.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.56 | $9.85 |
| 52 Week High | $25.00 | $15.37 |
Technical Indicators
Market Signals| Indicator | PLSE | CIM |
|---|---|---|
| Relative Strength Index (RSI) | 55.43 | 44.43 |
| Support Level | $13.17 | $12.30 |
| Resistance Level | $14.91 | $12.81 |
| Average True Range (ATR) | 0.78 | 0.25 |
| MACD | 0.05 | -0.04 |
| Stochastic Oscillator | 59.50 | 26.03 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.